Magazine article from our research archive:

Imiquimod confers no short-term cosmetic benefit for surgical wounds

National report - Daily topical treatment of surgical excision sites with imiquimod 5 parcent cream is well-tolerated, but at least in the short-run, it does not appear to have any benefit for enhancing cosmetic outcomes, according to Brian Berman, M.D., Ph.D., professor of dermatology and internal medicine at the University of Miami School of Medicine, Miami.

"The potential for imiquimod to improve cosmesis of postsurgical scars was strongly supported by research detailing its mechanisms of action," he tells Dermatology Times.

"Although the treatment is well-tolerated when applied to sutured surgical wounds and does not increase the risk of wound complications such as infection and ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!